Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 4 results for "HCL Me G1"

Design and Synthesis of a Cell-Permeable, Drug-Like Small Mole...

Introduction Polo-like kinases (Plks) 14 play critical roles in numerous cell cycle-related activities including the initiation of mitosis, chromosome segregation, centrosome maturation, bipolar-spindle formation, regulation of the ... Plosone.org, 4 days ago

Enforcement Report for September 03, 2014

Food Oxyphen XR, 12 HR / CLINICAL STRENGTH FAT BURNER, 45 FAST ACTING EXTENDED RELEASE CAPSULES, Distributed by Beta Labs, LTD, Newark, DE 19711, UPC 670541599747 Lot #s 200910 and 200911, Exp 10/16 ...
 U.S. Food and Drug Administration1 week ago

Synthesis of Non-linear Protein Dimers through a Genetically Encoded Thiol-ene Reaction

Introduction Covalent attachment of proteins to ligands, polymers, and surfaces creates macromolecules combining specific biological function with favorable physical and chemical properties. For example, studying biological processes in their ...
 Plosone.org1 week ago

Materials and methods for prevention and treatment of RNA viral diseases

The subject invention concerns a method of inhibiting an RNA virus infection within a patient by increasing the amount of 2-5 oligoadenylate synthetase (2-5 AS) activity within the patient. Preferably, the preventative and therapeutic methods of the ...
 PharmCast2 weeks ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less